tiprankstipranks
Keros Therapeutics downgraded to Neutral from Outperform at Wedbush
PremiumThe FlyKeros Therapeutics downgraded to Neutral from Outperform at Wedbush
1M ago
Keros Therapeutics price target lowered to $15 from $40 at Piper Sandler
Premium
The Fly
Keros Therapeutics price target lowered to $15 from $40 at Piper Sandler
1M ago
Keros Therapeutics price target lowered to $41 from $44 at Scotiabank
Premium
The Fly
Keros Therapeutics price target lowered to $41 from $44 at Scotiabank
1M ago
Keros Therapeutics voluntarily halts all dosing of Phase 2 TROPOS trial
PremiumThe FlyKeros Therapeutics voluntarily halts all dosing of Phase 2 TROPOS trial
1M ago
Keros Therapeutics Updates on Clinical Trials and Safety
Premium
Company Announcements
Keros Therapeutics Updates on Clinical Trials and Safety
1M ago
Keros Therapeutics price target lowered to $43 from $100 at Truist
Premium
The Fly
Keros Therapeutics price target lowered to $43 from $100 at Truist
2M ago
Keros Therapeutics price target lowered to $47 from $100 at H.C. Wainwright
PremiumThe FlyKeros Therapeutics price target lowered to $47 from $100 at H.C. Wainwright
2M ago
BofA cuts Keros target to $33, says ‘story still intact’ despite ‘setback’
Premium
The Fly
BofA cuts Keros target to $33, says ‘story still intact’ despite ‘setback’
2M ago
Keros Therapeutics downgraded to Hold from Buy at TD Cowen
Premium
The Fly
Keros Therapeutics downgraded to Hold from Buy at TD Cowen
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100